The BBIBP-CorV inactivated COVID-19 vaccine induces robust and persistent humoral responses to SARS-CoV-2 nucleocapsid, besides spike protein in healthy adults

Vaccination is one of the best ways to control the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic. Among the various SARS-CoV-2 vaccines approved for use, the BBIBP-CorV inactivated vaccine has been widely used in 93 countries. In order to understand deeply the protective mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qinjin, Ning, Jie, Chen, Ying, Li, Bin, Shi, Liang, He, Taojun, Zhang, Fang, Chen, Xingchi, Zhai, Aixia, Wu, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672472/
https://www.ncbi.nlm.nih.gov/pubmed/36406456
http://dx.doi.org/10.3389/fmicb.2022.1008420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672472/
https://www.ncbi.nlm.nih.gov/pubmed/36406456
http://dx.doi.org/10.3389/fmicb.2022.1008420

Ejemplares similares